Omeros Corp (OMER)
3.07
0.00 (0.00%)
USD |
NASDAQ |
Apr 24, 14:23
Omeros Cash from Investing (TTM): 27.45M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 27.45M |
September 30, 2023 | -197.28M |
June 30, 2023 | -221.45M |
March 31, 2023 | -232.08M |
December 31, 2022 | -127.56M |
September 30, 2022 | 93.34M |
June 30, 2022 | 78.24M |
March 31, 2022 | 83.91M |
December 31, 2021 | 193.71M |
September 30, 2021 | 89.29M |
June 30, 2021 | -47.00M |
March 31, 2021 | -44.82M |
December 31, 2020 | -67.03M |
September 30, 2020 | -114.27M |
June 30, 2020 | 13.47M |
March 31, 2020 | -3.912M |
December 31, 2019 | -3.401M |
September 30, 2019 | 33.48M |
June 30, 2019 | 57.20M |
March 31, 2019 | 27.89M |
December 31, 2018 | 25.15M |
September 30, 2018 | 32.94M |
June 30, 2018 | -59.66M |
March 31, 2018 | -39.72M |
December 31, 2017 | -37.60M |
Date | Value |
---|---|
September 30, 2017 | -49.04M |
June 30, 2017 | -10.04M |
March 31, 2017 | -20.30M |
December 31, 2016 | -16.34M |
September 30, 2016 | -2.877M |
June 30, 2016 | 32.08M |
March 31, 2016 | 56.12M |
December 31, 2015 | -20.61M |
September 30, 2015 | -13.57M |
June 30, 2015 | -13.10M |
March 31, 2015 | -17.02M |
December 31, 2014 | 6.157M |
September 30, 2014 | -13.26M |
June 30, 2014 | -17.70M |
March 31, 2014 | -39.71M |
December 31, 2013 | 7.909M |
September 30, 2013 | 21.18M |
June 30, 2013 | -18.93M |
March 31, 2013 | -11.88M |
December 31, 2012 | -0.907M |
September 30, 2012 | -1.88M |
June 30, 2012 | 32.52M |
March 31, 2012 | 38.27M |
December 31, 2011 | 16.91M |
September 30, 2011 | 2.503M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-232.08M
Minimum
Mar 2023
193.71M
Maximum
Dec 2021
-20.46M
Average
-3.401M
Median
Dec 2019
Cash from Investing (TTM) Benchmarks
Aspira Womens Health Inc | -0.024M |
Ardelyx Inc | -131.25M |
Panbela Therapeutics Inc | -- |
Ensysce Biosciences Inc | 0.00 |
MAIA Biotechnology Inc | -- |